Gary J. Beck
13Patents
6h-index
5Co-inventors
55Inventor score
Filing activity: Sep 2, 1999 → Nov 2, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6358935B1 | Preserved cyclodextrin-containing compositions | Human Necessities | 27 | Expired |
| US7030149B2 | Combination of brimonidine timolol for topical ophthalmic use | Human Necessities | 26 | Expired |
| US6723353B2 | Preserved cyclodextrin-containing compositions | Human Necessities | 18 | Expired |
| US7320976B2 | Combination of brimonidine and timolol for topical ophthalmic use | Human Necessities | 15 | Expired |
| US7642258B2 | Combination of brimonidine and timolol for topical ophthalmic use | Human Necessities | 14 | Active |
| US7323463B2 | Combination of brimonidine and timolol for topical ophthalmic use | Human Necessities | 12 | Expired |
| US8133890B2 | Combination of brimonidine and timolol for topical ophthalmic use | Human Necessities | 6 | Active |
| US8354409B2 | Combination of brimonidine and timolol for topical ophthalmic use | Human Necessities | 5 | Active |
| US8748425B2 | Combination of brimonidine and timolol for topical ophthalmic use | Human Necessities | 5 | Active |
| US9474751B1 | Combination of brimonidine and timolol for topical ophthalmic use | Human Necessities | 2 | Active |
| US9907801B1 | Combination of brimonidine and timolol for topical ophthalmic use | Human Necessities | 0 | Active |
| US9770453B2 | Combination of brimonidine and timolol for topical ophthalmic use | Human Necessities | 0 | Active |
| US9907802B1 | Combination of brimonidine and timolol for topical ophthalmic use | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.